Antiviral drug discovery for emerging diseases and bioterrorism threats
General Material Designation
[Electronic Resource]
First Statement of Responsibility
/ edited by Paul F. Torrence
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Hoboken, N.J.
Name of Publisher, Distributor, etc.
: Wiley-Interscience,
Date of Publication, Distribution, etc.
, c2005.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
x, 420 p. ill. 24 cm.
NOTES PERTAINING TO PUBLICATION, DISTRIBUTION, ETC.
Text of Note
e
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
ng
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
The discovery and development of new antivirals for smallpox / E.R. Kern -- Prevention of viral infection by immunocamouflage of target tissues / L. McCoy, M.D. Scott -- Viral evasion of the interferon system : novel targets for drug discovery / L. Powell, P.F. Torrence -- The emergence of pandemic influenza : bioterrorist vs. mother nature / J. S. Oxford, A. Catchpole, R. Lambkin -- Novel approach to smallpox (variola) inhibitors / A. Rich, B. Jacobs -- Structure-based design of anti-SARS drug / R. Hilgenfeld.
Text of Note
Viral bioterrorism and antiviral countermeasures / M. Bray -- Research on emerging and bioterror threats / C. Tseng -- Antiviral drug targets and strategies for emerging viral diseases and bioterrorism threats / E. de Clercq -- Perspectives for the therapy against arenavirus infections / E.B. Damonte, C.C. Garcia -- S-adenosylhomocysteine hydrolase inhibitors as a source of anti-filovirus agents / S.W. Schneller, M. Yang -- Antiviral strategies for Ebola virus / R.N. Harty and J. M. Licata -- IMPDH inhibitors : discovery of antiviral agents against emerging diseases / V. Nair -- Lethal mutagenesis : exploiting error-prone replication of riboviruses for -- Antiviral therapy / J.D. Graci, C.E. Cameron -- Structural biology of flavivral replications and opportunities for drug design / K. Murthy -- Confronting new and old antiviral threats : broad spectrum potential of prenylation inhibitors / M. Elazar, J.S. Glenn --
TOPICAL NAME USED AS SUBJECT
Antiviral agents
Drug development
Bioterrorism
Antiviral Agents- therapeutic use
Bioterrorism- prevention & control
Communicable Diseases, Emerging- drug therapy
Communicable Diseases, Emerging- prevention & control